HomeCompareVAPO vs PLD

VAPO vs PLD: Dividend Comparison 2026

VAPO yields 92.17% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $3.69M in total portfolio value· pulled ahead in Year 10
10 years
VAPO
VAPO
● Live price
92.17%
Share price
$2.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.81M
Annual income
$897,478.47
Full VAPO calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — VAPO vs PLD

📍 PLD pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVAPOPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VAPO + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VAPO pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VAPO
Annual income on $10K today (after 15% tax)
$7,834.10/yr
After 10yr DRIP, annual income (after tax)
$762,856.70/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $3,705,114.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VAPO + PLD for your $10,000?

VAPO: 50%PLD: 50%
100% PLD50/50100% VAPO
Portfolio after 10yr
$4.66M
Annual income
$3,076,957.32/yr
Blended yield
66.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

VAPO
Analyst Ratings
2
Buy
3
Hold
1
Sell
Consensus: Hold
Price Target
$1.60
-26.3% upside vs current
Range: $1.60 — $1.60
Altman Z
-14.2
Piotroski
4/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VAPO buys
0
PLD buys
0
No recent congressional trades found for VAPO or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVAPOPLD
Forward yield92.17%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$2.81M$6.50M
Annual income after 10y$897,478.47$5,256,436.18
Total dividends collected$2.49M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy
Analyst price target$1.60$136.00

Year-by-year: VAPO vs PLD ($10,000, DRIP)

YearVAPO PortfolioVAPO Income/yrPLD PortfolioPLD Income/yrGap
1$19,917$9,216.59$11,255$555.24+$8.7KVAPO
2$38,466$17,155.42$13,062$1,018.59+$25.4KVAPO
3$72,125$30,965.76$15,903$1,926.67+$56.2KVAPO
4$131,436$54,262.79$20,839$3,823.32+$110.6KVAPO
5$233,053$92,416.55$30,464$8,166.08+$202.6KVAPO
6$402,513$153,146.25$52,054$19,457.30+$350.5KVAPO
7$677,889$247,199.53$109,886$54,188.93+$568.0KVAPO
8$1,114,424$389,082.88$304,030$186,451.18+$810.4KVAPO
9$1,790,226$597,792.36$1,166,125$840,813.32+$624.1KVAPO
10← crossover$2,813,020$897,478.47$6,504,190$5,256,436.18$3.69MPLD

VAPO vs PLD: Complete Analysis 2026

VAPOStock

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Full VAPO Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this VAPO vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VAPO vs SCHDVAPO vs JEPIVAPO vs OVAPO vs KOVAPO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.